Clinical Trials Browser

Mesothelioma, Malignant, Appendiceal Neoplasms, Ascites, Gallbladder Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms, Pleural Effusion, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms

NCT02949791 2018-02-23

HIPEC-IAP

Phase 2 Completed

38 enrolled

Gastrointestinal

Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT02834169 2017-08-22

RENAPE

Unknown

2,171 enrolled

Pseudomyxoma Peritonei, Cystadenocarcinoma, Serous, Desmoplastic Small Round Cell Tumor

NCT02374411 2017-02-08

Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients

Completed

55 enrolled

GastrointestinalGynecologicSarcoma

Adenocarcinoma, Appendiceal Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Pseudomyxoma Peritonei, Sarcoma, Uterine Neoplasms

NCT03034850 2017-01-27

Thrombin Generation and Platelet Activation in CRS/HIPEC

Completed

27 enrolled

GynecologicOther solid neoplasmThoracic

Mesothelioma, Peritoneal Neoplasms, Pseudomyxoma Peritonei

NCT01764789 2015-10-09

Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer

Phase NA Completed

39 enrolled

BreastGynecologic

Carcinoma, Ovarian Epithelial, Anxiety Disorders, Breast Neoplasms, Uterine Cervical Neoplasms, Depression, Fallopian Tube Neoplasms, Fatigue, Leydig Cell Tumor, Pain, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Gestational Trophoblastic Disease

NCT01652794 2015-08-04

Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer

Phase 1 Completed

12 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Leydig Cell Tumor, Pseudomyxoma Peritonei, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT01427101 2011-09-01

Results of CRS and Debulking in PMP Patients

Unknown

Pseudomyxoma Peritonei

Clinical Trials

HIPEC-PMP

TRANSCAPE

Pseudovax

One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei

Flura-seq for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Transcriptome of Pseudomyxoma Peritonei

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

REVERSE

Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

HIPEC for Peritoneal Carcinomatosis

HIPEC

Severe Neutropenia After HIPEC Using Mitomycin-C

Gastrointestinal Microbiome Study of Appendiceal Cancer

Phase I Trial HIPEC With Nal-irinotecan

ACAPP

ERAS® Guidelines Validation of CRS With or Without HIPEC

PSM

What Are the Experiences of Patients With Pseudomyxoma Peritonei?

PIPACRegis